<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0010">
 <label>Table 2</label>
 <caption>
  <p>List of different types of nanoparticles used for the treatment of other viral infections.</p>
 </caption>
 <alt-text id="al0035">Table 2</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>S.noS.no</th>
    <th>Nanoparticle</th>
    <th>Virus</th>
    <th>Mechanism of action</th>
    <th>Inference</th>
    <th>References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center">1</td>
    <td align="center">Silver nanoparticles (AgNPs)</td>
    <td align="center">Poliovirus type-1</td>
    <td align="center">–</td>
    <td>AgNPs based products were ideal for biomedical applications and to fight against viral infections</td>
    <td align="center">[
     <xref rid="bb0730" ref-type="bibr">146</xref>]
    </td>
   </tr>
   <tr>
    <td>2</td>
    <td align="center">siRNA-modified Polyethylenimine (PEI) encapsulated AgNPs</td>
    <td align="center">Enterovirus 71 (EV71)</td>
    <td align="center">Prevent DNA fragmentation, chromatin
     <break/>condensation and activation of caspase-3 and block entry of EV71 TO host cell
    </td>
    <td>Surface decorated AgNPs with PEI and siRNA might be a prospective silver species with antiviral properties for treatment of viral diseases.</td>
    <td align="center">[
     <xref rid="bb0735" ref-type="bibr">147</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">3</td>
    <td align="center">Glutathione-capped Ag
     <sub>2</sub>S nanoclusters (NCs)
    </td>
    <td align="center">Porcine epidemic diarrhea virus (PEDV) as a model of coronavirus</td>
    <td align="center">Inhibits the synthesis of viral negative-strand RNA and viral budding</td>
    <td>The results suggest the possibility to develop efficient anti-SARS or anti-MARS reagents based on Ag
     <sub>2</sub>S NCs
    </td>
    <td align="center">[
     <xref rid="bb0740" ref-type="bibr">148</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">4</td>
    <td align="center">Amantadine (Ada), on the outermost layer of PVP–PEG-coated silver nanorods (Ada–PVP–PEG silver nanorods)</td>
    <td align="center">Human immunodeficiency virus (HIV)</td>
    <td align="center">Ada surface-modified silver nanorods promote HIV vaccine-triggered cytotoxic lymphocytes to produce around eightfold stronger tumor necrosis factor alpha in vivo</td>
    <td>Surface modifications of nanomaterials in fundamentally improving the immunotherapy of HIV vaccine against HIV-infected cells.</td>
    <td align="center">[
     <xref rid="bb0745" ref-type="bibr">149</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">5</td>
    <td align="center">AgNP</td>
    <td align="center">Respiratory syncytial virus (RSV)</td>
    <td align="center">NPs attach to viral glycoproteins, and block entry into the host cell.</td>
    <td>AgNP-mediated reduction in RSV replication, both in epithelial cell lines and in experimentally infected BALB/c mice</td>
    <td align="center">[
     <xref rid="bb0750" ref-type="bibr">150</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">6</td>
    <td align="center">Nonlinear globular G2 dendrimer</td>
    <td align="center">Rabies virus</td>
    <td align="center">–</td>
    <td>Adjuvanticity efficacy</td>
    <td align="center">[
     <xref rid="bb0755" ref-type="bibr">151</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">7</td>
    <td align="center">Ammonium-terminated amphiphilic Janus dendrimers</td>
    <td align="center">Hepatitis C virus (HCV)</td>
    <td align="center">Inhibit HCV replication by interacting with viral protein</td>
    <td>Nontoxic drug-loaded nanoaggregates inhibit HCV replication at low camptothecin concentration.</td>
    <td align="center">[
     <xref rid="bb0760" ref-type="bibr">152</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">8</td>
    <td align="center">Modified dendrimer NPs</td>
    <td align="center">Venezuelan equine encephalitis virus (VEEV) replicon RNAs Zika virus</td>
    <td align="center">Activation of both CD8+ T-cell and viral E protein-specific IgG responses</td>
    <td>This approach can be used to evaluate new candidate antigens and identify immune correlates without the use of live virus.</td>
    <td align="center">[
     <xref rid="bb0765" ref-type="bibr">153</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">9</td>
    <td align="center">Glycodendrofullerenes Carbohydrate moieties (Mannose, Galactose)</td>
    <td align="center">Pseudotyped viral particles
     <break/>(Ebola virus glycoprotein)
    </td>
    <td align="center">Blocking the dendritic cell–specific
     <break/>intercellular adhesion molecule-3–
     <break/>grabbing non-integrin receptor
    </td>
    <td>Inhibition of viral attachment
     <break/>leading to inhibited viral entry
    </td>
    <td align="center">[
     <xref rid="bb0770" ref-type="bibr">154</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">10</td>
    <td align="center">Gold (Au)/iron-oxide magnetic NP-decorated Carbon nanotubes (CNTs)</td>
    <td align="center">H1N1, norovirus</td>
    <td align="center">DNA hybridization</td>
    <td>High sensitivity and selectivity detection of viral DNA</td>
    <td align="center">[
     <xref rid="bb0775" ref-type="bibr">155</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">11</td>
    <td align="center">Monodispersed gold nanoparticles</td>
    <td align="center">Herpes simplex virus</td>
    <td align="center">Prevented viral attachment and penetration into the Vero cells.</td>
    <td>Gold nanoparticles were proposed as a safer alternative in virus chemotherapy</td>
    <td align="center">[
     <xref rid="bb0780" ref-type="bibr">156</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">12</td>
    <td align="center">Polyvinylpyrrolidone (PVP)/stearic acid (SA)-polyethylene glycol (PEG) NP</td>
    <td align="center">HIV</td>
    <td align="center">Appreciable cellular internalization</td>
    <td>Favorable loading, sustained release, hemocompatibility and nontoxicity</td>
    <td align="center">[
     <xref rid="bb0540" ref-type="bibr">108</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">13</td>
    <td align="center">Lactoferrin NPs</td>
    <td align="center">HIV</td>
    <td align="center">–</td>
    <td align="center">The triple-drug loaded nanoparticles have various advantages against soluble (free) drug combination in terms of enhanced bioavailability, improved PK profile and diminished drug-associated toxicity.</td>
    <td align="center">[
     <xref rid="bb0785" ref-type="bibr">157</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">14</td>
    <td align="center">Amide functionalized alginate NPs</td>
    <td align="center">HIV</td>
    <td>Inhibits viral transcriptase</td>
    <td>Effective antiviral delivery</td>
    <td align="center">[
     <xref rid="bb0790" ref-type="bibr">158</xref>]
    </td>
   </tr>
   <tr>
    <td align="center">15</td>
    <td align="center">Glycyrrhizic-acid-based carbon dots</td>
    <td align="center">Porcine reproductive and respiratory syndrome virus (PRRSV)</td>
    <td align="center">Gly-CDs can inhibit PRRSV invasion and replication, stimulate antiviral innate immune responses, and inhibit the accumulation of intracellular reactive oxygen species (ROS) caused by PRRSV infection.</td>
    <td>Gly-CDs possess extraordinary antiviral activity with multisite inhibition mechanisms, providing a promising candidate</td>
    <td align="center">[
     <xref rid="bb0795" ref-type="bibr">159</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
